1359983-12-2Relevant academic research and scientific papers
AUTOTAXIN INHIBITORS AND USES THEREOF
-
Paragraph 00324; 00330, (2016/12/22)
Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
AUTOTAXIN INHIBITOR COMPOUNDS
-
Paragraph 00407, (2015/04/15)
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.
AUTOTAXIN INHIBITOR COMPOUNDS
-
Paragraph 00344; 00306, (2015/06/08)
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorde
Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
-
Paragraph 0261, (2015/06/16)
Described herein are methods and compositions for treatment or prevention of metabolic disorder(s) in an individual. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
AUTOTAXIN INHIBITORS AND USES THEREOF
-
Page/Page column 193-194, (2012/03/11)
Described herein are compounds that are inhibitors of autotaxin. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such inhibitors, alone and in combination with other compounds, for treating autotaxin-dependent or autotaxin-mediated conditions or diseases.
